These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35328504)

  • 21. Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy.
    Wojciechowska M; Sobczak K; Kozlowski P; Sedehizadeh S; Wojtkowiak-Szlachcic A; Czubak K; Markus R; Lusakowska A; Kaminska A; Brook JD
    Sci Rep; 2018 Apr; 8(1):5885. PubMed ID: 29651162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort.
    Cumming SA; Jimenez-Moreno C; Okkersen K; Wenninger S; Daidj F; Hogarth F; Littleford R; Gorman G; Bassez G; Schoser B; Lochmüller H; van Engelen BGM; Monckton DG;
    Neurology; 2019 Sep; 93(10):e995-e1009. PubMed ID: 31395669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of exosomal muscle-specific miRNAs in serum of myotonic dystrophy patients relating to muscle disease progress.
    Koutsoulidou A; Photiades M; Kyriakides TC; Georgiou K; Prokopi M; Kapnisis K; Lusakowska A; Nearchou M; Christou Y; Papadimas GK; Anayiotos A; Kyriakou K; Kararizou E; Zamba Papanicolaou E; Phylactou LA
    Hum Mol Genet; 2017 Sep; 26(17):3285-3302. PubMed ID: 28637233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
    Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
    Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redox imbalance in peripheral blood of type 1 myotonic dystrophy patients.
    Nikolić-Kokić A; Marinković D; Perić S; Stević Z; Spasić MB; Blagojević D; Rakocˇević-Stojanović V
    Redox Rep; 2016 Sep; 21(5):232-7. PubMed ID: 26817806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.
    Santoro M; Masciullo M; Silvestri G; Novelli G; Botta A
    Clin Genet; 2017 Oct; 92(4):355-364. PubMed ID: 27991661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
    Mootha VV; Hansen B; Rong Z; Mammen PP; Zhou Z; Xing C; Gong X
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4579-4585. PubMed ID: 28886202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients.
    Fernandez-Costa JM; Garcia-Lopez A; Zuñiga S; Fernandez-Pedrosa V; Felipo-Benavent A; Mata M; Jaka O; Aiastui A; Hernandez-Torres F; Aguado B; Perez-Alonso M; Vilchez JJ; Lopez de Munain A; Artero RD
    Hum Mol Genet; 2013 Feb; 22(4):704-16. PubMed ID: 23139243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.
    Furling D; Lemieux D; Taneja K; Puymirat J
    Neuromuscul Disord; 2001 Nov; 11(8):728-35. PubMed ID: 11595515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.
    Botta A; Vallo L; Rinaldi F; Bonifazi E; Amati F; Biancolella M; Gambardella S; Mancinelli E; Angelini C; Meola G; Novelli G
    Gene Expr; 2007; 13(6):339-51. PubMed ID: 17708420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
    Ozimski LL; Sabater-Arcis M; Bargiela A; Artero R
    Biol Rev Camb Philos Soc; 2021 Apr; 96(2):716-730. PubMed ID: 33269537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.
    Ueki J; Nakamori M; Nakamura M; Nishikawa M; Yoshida Y; Tanaka A; Morizane A; Kamon M; Araki T; Takahashi MP; Watanabe A; Inagaki N; Sakurai H
    Sci Rep; 2017 Feb; 7():42522. PubMed ID: 28211918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pleiotropic expression of the myotonic dystrophy protein kinase gene illustrates the complex relationships between genetic, biological and clinical covariates of male aging.
    Brisson D; Houde G; St-Pierre J; Vohl MC; Mathieu J; Gaudet D
    Aging Male; 2002 Dec; 5(4):223-32. PubMed ID: 12630069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
    Winkler NS; Milone M; Martinez-Thompson JM; Raja H; Aleff RA; Patel SV; Fautsch MP; Wieben ED; Baratz KH
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3053-3057. PubMed ID: 30025114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myotonic dystrophies.
    Huang CC; Kuo HC
    Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1.
    Huin V; Vasseur F; Schraen-Maschke S; Dhaenens CM; Devos P; Dupont K; Sergeant N; Buée L; Lacour A; Hofmann-Radvanyi H; Sablonnière B
    J Neurol; 2013 Apr; 260(4):998-1003. PubMed ID: 23161457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial dysfunction in myotonic dystrophy type 1.
    Gramegna LL; Giannoccaro MP; Manners DN; Testa C; Zanigni S; Evangelisti S; Bianchini C; Oppi F; Poda R; Avoni P; Lodi R; Liguori R; Tonon C
    Neuromuscul Disord; 2018 Feb; 28(2):144-149. PubMed ID: 29289451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective measurement of quality of life in myotonic dystrophy type 1.
    Peric S; Heatwole C; Durovic E; Kacar A; Nikolic A; Basta I; Marjanovic A; Stevic Z; Lavrnic D; Rakocevic Stojanovic V
    Acta Neurol Scand; 2017 Dec; 136(6):694-697. PubMed ID: 28660733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.